On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to FDA Guidance on ZIKV Testing Strategy. Please register for CTS FDA Guidance ZIKV Testing Strategy Webinar by clicking the link: CTS FDA Guidance ZIKV Testing Strategy Webinar
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...